Solventum Corporation (LON:0AD1)

Market Cap	10.36B -0.4%
Revenue (ttm)	6.25B +2.3%
Net Income	1.13B +111.7%
EPS	6.49 +110.2%
Shares Out	n/a
PE Ratio	9.14
Forward PE	12.96
Dividend	n/a
Ex-Dividend Date	n/a

Volume	87
Average Volume	69
Open	76.70
Previous Close	n/a
Day's Range	76.70 - 76.70
52-Week Range	64.91 - 85.55
Beta	n/a
RSI	52.77
Earnings Date	Feb 26, 2026

About Solventum

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates in three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions for negative pressure wound therapy, advanced wound dressings, advanced skin care, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical e...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 2023
• Employees: 22,000
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0AD1

Financial Performance

In 2024, Solventum's revenue was $8.25 billion, an increase of 0.70% compared to the previous year's $8.20 billion. Earnings were $479.00 million, a decrease of -64.41%.

Financial numbers in USD